Literature DB >> 15286707

Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.

Celia Vogel1, Anne Kienitz, Irmgard Hofmann, Rolf Müller, Holger Bastians.   

Abstract

Treatment of cells with microtubule inhibitors results in activation of the mitotic spindle assembly checkpoint, leading to mitotic arrest before anaphase. Upon prolonged treatment, however, cells can adapt and exit mitosis aberrantly, resulting in the occurrence of tetraploid cells in G1. Those cells subsequently arrest in postmitotic G1 due to the activation of a p53-dependent G1 checkpoint. Failure of the G1 checkpoint leads to endoreduplication and further polyploidization. Using HCT116 and isogenic p53-deficient or spindle checkpoint compromised derivatives, we show here that not only p53 but also a functional spindle assembly checkpoint is required for postmitotic G1 checkpoint function. During transient mitotic arrest, p53 stabilization and activation is triggered by a pathway independent of ATM/ATR, Chk1 and Chk2. We further show that a prolonged spindle checkpoint-mediated mitotic arrest is required for proper postmitotic G1 checkpoint function. In addition, we demonstrate that polyploid cells are inhibited to re-enter mitosis by an additional checkpoint acting in G2. Thus, during a normal cell cycle, polyploidization and subsequent aneuploidization is prevented by the function of the mitotic spindle checkpoint, a p53-dependent G1 checkpoint and an additional G2 checkpoint.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286707     DOI: 10.1038/sj.onc.1207860

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Authors:  Catherine J Drummond; Graeme J Finlay; Laura Broome; Elaine S Marshall; Emma Richardson; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

Review 2.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 3.  Illicit survival of cancer cells during polyploidization and depolyploidization.

Authors:  I Vitale; L Galluzzi; L Senovilla; A Criollo; M Jemaà; M Castedo; G Kroemer
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

4.  Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia.

Authors:  Martin Oberringer; Martina Jennewein; Sandra E Motsch; Tim Pohlemann; Andreas Seekamp
Journal:  Histochem Cell Biol       Date:  2005-05-24       Impact factor: 4.304

5.  Apoptosis regulation in tetraploid cancer cells.

Authors:  Maria Castedo; Arnaud Coquelle; Sonia Vivet; Ilio Vitale; Audrey Kauffmann; Philippe Dessen; Marie O Pequignot; Noelia Casares; Alexandre Valent; Shahul Mouhamad; Elise Schmitt; Nazanine Modjtahedi; William Vainchenker; Laurence Zitvogel; Vladimir Lazar; Carmen Garrido; Guido Kroemer
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

Review 6.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

7.  Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells.

Authors:  Susan A Heilman; Joshua J Nordberg; Yingwang Liu; Greenfield Sluder; Jason J Chen
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

Review 8.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

9.  Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.

Authors:  Daniel Henry Marks; Rozario Thomas; Yvette Chin; Riddhi Shah; Christine Khoo; Robert Benezra
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

Review 10.  Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

Authors:  W Brian Dalton; Vincent W Yang
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.